AnalystsJulian Harrison
Julian Harrison's Stock Forecasts

Analyst Ranking
Top 4%
#205 out of 5184 analysts
Average Return
+34.79%
Win Rate
59%53 out of 90
Risk vs Reward
Poor
Good

Julian Harrison's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Cymabay Therapeutics IncCBAY
+262.63%$8.91$32.31
2023-03-09 -
2024-03-08
Strong Buy
Prometheus Biosciences IncRXDX
+233.20%$60.00$199.92
2022-10-02 -
2023-06-15
Strong Buy
Cymabay Therapeutics IncCBAY
+212.31%$10.40$32.48
2023-05-15 -
2024-03-21
Strong Buy
Cymabay Therapeutics IncCBAY
+199.91%$10.83$32.48
2023-05-01 -
2024-03-21
Strong Buy
Cymabay Therapeutics IncCBAY
+193.67%$11.06$32.48
2023-07-04 -
2024-03-21
Strong Buy

Julian Harrison Analyst Color

Get additional color on Julian Harrison's coverage of popular stocks

Julian Harrison's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Maze Therapeutics IncMAZE
4Strong Buy$46.00+6.09%Maintains
13 days ago
Mereo Biopharma Group PLCMREO
3Strong Buy$1.00+122.72%Reiterates
13 days ago
Spyre Therapeutics IncSYRE
4Strong Buy$70.00+111.23%Reiterates
14 days ago
Liquidia CorpLQDA
6Strong Buy$49.00+16.92%Reiterates
17 days ago
Oruka Therapeutics IncORKA
4Strong Buy$73.00+107.62%Maintains
17 days ago
Moonlake ImmunotherapeuticsMLTX
3Strong Buy$24.00+47.69%Upgrades
21 days ago
Ardelyx IncARDX
1Strong Buy$17.00+116.28%Maintains
21 days ago
Abivax SaABVX
4Strong Buy$150.00+31.60%Maintains
22 days ago
Rezolute IncRZLT
5Strong Buy$5.00+47.93%Reiterates
22 days ago
Apogee Therapeutics IncAPGE
4Strong Buy$137.00+93.80%Maintains
23 days ago
Nektar TherapeuticsNKTR
2Strong Buy$118.00+228.60%Maintains
a month ago
Akebia Therapeutics IncAKBA
3Strong Buy$5.00+244.83%Reiterates
2 months ago
Theravance Biopharma IncTBPH
3Strong Buy$40.00+110.19%Maintains
2 months ago
Cullinan Therapeutics IncCGEM
2Strong Buy$38.00+220.68%Maintains
2 months ago
Cartesian Therapeutics IncRNAC
2Strong Buy$44.00+504.40%Maintains
3 months ago
Connect Biopharma Holdings LtdCNTB
2Strong Buy$10.00+303.23%Reiterates
3 months ago
Viridian Therapeutics IncVRDN
4Strong Buy$61.00+81.44%Reiterates
3 months ago
Protagonist Therapeutics IncPTGX
3Strong Buy$82.00+0.29%Reiterates
3 months ago
Climb Bio IncCLYM
3Strong Buy$8.00+55.04%Reiterates
3 months ago
Tvardi Therapeutics IncTVRD
1Strong Buy$15.00+269.46%Maintains
4 months ago
Jade Biosciences IncJBIO
4Strong Buy$28.00+79.03%Initiates Coverage On
4 months ago
Avalo Therapeutics IncAVTX
2Strong Buy$40.00+167.20%Reiterates
4 months ago
Outlook Therapeutics IncOTLK
4Strong Buy$9.00N/AMaintains
a year ago
Aclaris Therapeutics IncACRS
3Strong Buy$8.00N/AUpgrades
a year ago
Vyne Therapeutics IncVYNE
1Strong Buy$8.00N/AInitiates Coverage On
a year ago
Anaptysbio IncANAB
1Strong Buy$55.00N/AInitiates Coverage On
2 years ago
Matinas Biopharma Holdings IncMTNB
1Strong Buy$150.00N/AReinstates
2 years ago
Cymabay Therapeutics IncCBAY
7Strong Buy$24.00N/AMaintains
2 years ago
Keros Therapeutics IncKROS
2Strong Buy$105.00N/AMaintains
3 years ago
Prometheus Biosciences IncRXDX
3Strong Buy$181.00N/AMaintains
3 years ago
Biora Therapeutics IncBIOR
1Strong Buy$4.00N/AAssumes
4 years ago
United Therapeutics CorpUTHR
1HoldN/AN/AInitiates Coverage On
4 years ago
Morphic Holding IncMORF
1Strong Buy$64.00N/AInitiates Coverage On
4 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.